NVCT - Balance Sheet - Nuvectis Pharma, Inc.

Current Liabilities	8.89 M
Accounts Payable	2.5 M
Short-Term Debt	0
Other Current Liabilities	6.4 M
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020
ASSETS
Cash & Cash Equivalents	18.5	19.1	20.0	5.7	0
Short Term Investments	0	0	0	0	0
Receivables	0	0	0	0	0
Inventory	0	0	0	0	0
Other Current Assets	74 K	59 K	0.4	91 K	0
Total Current Assets	18.6	19.2	20.4	5.8	0
PP&E	0	0	0	0	0
Intangible Assets	0	0	0	0	0
Goodwill	0	0	0	0	0
Long Term Investments	0	0	0	0	0
Other Long Term Assets	0	0	0	0.8	0
Other Assets	0	0	0	0	0
Total Assets	18.6	19.2	20.4	6.7	0
LIABILITIES
Accounts Payable	2.5	2.8	2.9	1.1	10 K
Short Term Debt	0	0	0	0	0
Other Current Liabilities	6.4	4.2	3.3	1.4	0
Total Current Liabilities	8.9	7.0	6.2	2.4	10 K
Long Term Debt	0	0	0	0	0
Deferred Tax Income	0	0	0	0	0
Other Liabilities	0	0	0	0	0
Total Liabilities	8.9	7.0	6.2	17.7	10 K
EQUITY
Common Stock	0	0	14 752.4	0	0
Retained Earnings	(73.2)	(54.2)	(32.0)	(12.9)	10 K
Other Accumulative Comprehensive Income/Loss	0	0	(14 752.4)	0	0
Total Equity	9.7	12.2	14.2	(11.0)	10 K
Total Liabilities and Equity	18.6	19.2	20.4	6.7	0
SHARES OUTSTANDING
Common Shares Outstanding	17.1	15.6	12.7	12.7	12.7

Free